Weekly in Asia(0414-0420)
Taiwanese Company Excelsior Bio-System Invents Rapid Test Kit for African Swine Fever African swine fever (ASF) is a devastating infectious disease of pigs, usually deadly. ASF is responsible for serious …
Read MoreThe Next Generation Biotech Media
Taiwanese Company Excelsior Bio-System Invents Rapid Test Kit for African Swine Fever African swine fever (ASF) is a devastating infectious disease of pigs, usually deadly. ASF is responsible for serious …
Read MoreMedigen and Oncolys Grants an Exclusive License to Chugai on Liver Cancer Medicine OBP-301 Medigen Biotechnology Corp announced the licensing and capital tie-up agreements with Japanese partner Oncolys Biopharma regarding …
Read MoreChina National Biotec Group and ImmunoBiology Collaborate to Develop Next Generation Vaccine against Pneumococcal Infection Pneumococcal disease is an infection caused by Streptococcus pneumoniae bacteria. It is a major cause of mortality with approximately …
Read MoreNatera and BGI Genomics Announced Partnership to Commercialize Molecular Diagnostics in China The molecular diagnostics markets in China are rapidly growing, which driven by the rising incidence of cancer and …
Read MoreKemin Invests in China to Stay Ahead in Enzyme Production and Expand into Food and Clothing Industries Kemin Industries, a global leading ingredient manufacturer in blending enzymes for feed since …
Read MoreBurning Rock Completes RMB 850 Million for Series C Round of Funding and Aims to Build an International Leading Tumor Precision Medicine Brand Burning Rock officially announced the closing of …
Read MoreStarting from March 1st, the Value-Added Tax on 21 Drugs for Rare Diseases will be 3 percent in China On February 11th, the State Council of the People’s Republic of China …
Read MorePD-1 Immunotherapy and Targeted Small Molecule Combination Therapy Clinical Trial Approved On January 16, 2019, Kananji Medicine Technology (Shanghai) Co., Ltd., a wholly-owned subsidiary of Betta Pharmaceuticals Co., Ltd., received …
Read More